" class="no-js "lang="en-US"> James F. Chen - Medtech Alert
Saturday, September 23, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
James F. Chen

James F. Chen

About James F. Chen

1. Start up company CEO twice
2. One public, the other on its way
3. SaaS and VPN original thinker
4. 6 patents in Internet Security, VPN
5. Broad range of industry: Nuclear Power, Satellite launches, Telecom, Internet Security, and Healthcare IT

= Goals
Build a better world… at least try…

Specialties: EE/CS and Business Start-up

= Interests

I welcome all healthcare IT professionals to get connected with me. (Jchen@DrFirst.com)

Please state your interest beyond just request connection. Thanks!

Related Story

Fundraising

 $50 Million Follow-on Equity Investment from Sixth Street Growth Caps $135 Million Total in 2020-21 for DrFirst | Pharmtech Focus

$50M Investment Caps DrFirst $135 Million Total

May 13 2021

Health technology pioneer DrFirst today announced the closing of a $50 million equity investment from Sixth Street Growth, […]